Accumulation of p53 in infectious mononucleosis tissues

Human Pathology

Volumn 31, Issue 11, 2000, Pages 1397-1403

  Ehsan, Aamir ^a   Fan, Hongxin ^a   Eagan, Phyllis ^a   Siddiqui, Huma ^a   Gulley, Margaret ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

BZLF1; EBER1; Epstein Barr virus; Infectious mononucleosis; LMP1; p53

Indexed keywords

BAMH1 Z LEFTWARD READING FRAME 1 PROTEIN; EBV ENCODED RNA 1; LATENT MEMBRANE PROTEIN 1; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTIOUS MONONUCLEOSIS; LYMPHOID ORGAN; MALE; MONONUCLEAR CELL; PRESCHOOL CHILD; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VIRUS GENE; VIRUS REPLICATION;

EID: 0033710111     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2000.19447     Document Type: Article

References (38)

1. The switch between latency and replication of EBV
2. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state
3. Epstein-Barr virus infection in infectious mononucleosis: Virus latency, replication and phenotype of EBV-infected cells
4. Lyric replication of Epstein-Barr virus in the peripheral blood: Analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state
5. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual inflection route of Epstein-Barr virus
6. Epstein-Barr virus gene expression in lymphoid B-cells during acute infectious mononucleosis and clonality of the directly growing cell lines
7. Functional and physical interaction between p53 and BZLF1: Implication for Epstein-Barr virus latency
8. Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma
9. Accumulation of p53 protein correlates with tumor proliferative activity in EBV positive Burkitt's lymphoma
10. Increased rate of transcription contributes to elevated expression of the mutant p53 gene in Burkitt's lymphoma cells
11. Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells
12. Alterations of the p53 gene in Epstein-Barr virus associated immunodeficiency-related lymphomas
13. p53 is frequently murated in Burkitt's lymphoma cell lines
14. p53 mutation in human nasopharyngeal carcinomas
15. Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity
16. Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphomas
17. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease
18. Infectious mononucleosis in lymphoid tissue: Histopathology, in sire hybridization, and differential diagnosis
19. Detection and characterization of Epstein-Barr virus in clinical specimens
20. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: Association with mixed cellularity subtype and Hispanic American ethnicity
21. Accumulation of mutant p53 is associated with increased proliferation and poor clinical outcome in node-negative breast cancer
22. p53 is expressed in fifty percent of pre-invasive lesions of the head and neck epithelium
23. Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in nonimmunocompromised individuals
24. The p53 tumor suppressor gene
25. p53 function and dysfunction
26. p53 mutations in human cancers
27. Functional analysis of the p53 protein in AIDS-related non-Hodgkin's lymphomas and polymorphic lymphoproliferations
28. Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease
29. Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations
30. The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p 53 gene mutations
31. Identification of cellular target genes of the EBV transactivator Zta: Activation of TGF-Bigh3 and TGF-B1
32. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B-cells from programmed cell death
33. Levels of p53 in Epstein-Barr virus-infected cells determine cell fate: Apoptosis, cell cycle arrest at the G1/S boundary without apoptosis, cell cycle arrest at the G2/M boundary without apoptosis, or unrestricted proliferation
34. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest
35. Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus
36. Demonstration of Epstein-Barr virus replication in Reed-Sternberg cells of Hodgkin's disease
37. Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells
38. Apoptosis and Epstein-Barr virus in B cells